Outcome MD

Overview
News
Clinical Decision Support Systems?
Product stageSegments
Go-to-Market
?
Workflow management
?

OutcomeMD is a Los Angeles-based healthcare technology company that has developed an innovative outcome management and marketing system for healthcare providers. Founded by orthopedic surgeon Justin Saliman, MD, the company's platform leverages patient-reported outcomes (PROs) to improve patient care and provider performance across various medical specialties. The OutcomeMD system uses medically valid PRO measures to score and track patients' symptoms over time, providing a fitness tracker-like experience for patients and real-time data for healthcare providers to inform treatment decisions.

The platform aggregates patient scores, symptoms, confounding factor data, and electronic medical record (EMR) data to offer comprehensive insights. This approach not only enhances the shared medical decision-making process but also helps clinicians generate revenue by obtaining good outcomes, shifting focus from patient catering to patient care. OutcomeMD's system is designed to reduce complication rates, decrease overutilization of healthcare resources, and improve overall efficiency and effectiveness of care.

As of 2024, OutcomeMD has been working with clinicians, health systems, surgical centers, clinics, and hospitals across the US. The company's unique value proposition lies in its ability to financially benefit healthcare providers for actively tracking and utilizing patient-reported outcomes, which has catalyzed widespread adoption beyond research-focused usage to become integral in everyday clinical practice.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Suite 200 Los Angeles CA USA
Founded year:
2017
Employees:
11-50
IPO status:
Private
Total funding:
USD 3.7 mn
Last Funding:
USD 3.7 mn (Convertible Note; Dec 2022)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.